Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 11;12:761209. doi: 10.3389/fimmu.2021.761209

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Luo, Xue, Tang, Lin, Song, Liu, Yin, Huang, Wei, Mao, Wang and Sun

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The change of various indicators after anti-TB treatment. (A) Line graphs showing the expression of HLA-DR on IFN-γ⁺TNF-α⁺ cells in ATB patients before and after 3 months of anti-TB treatment. **P < 0.01 (Wilcoxon test). (B) Line graphs showing the levels of TBAg/PHA ratio in ATB patients before and after 3 months of anti-TB treatment. ***P < 0.001 (Wilcoxon test). (C) Line graphs showing the predictive values of diagnostic model in ATB patients before and after 3 months of anti-TB treatment. ***P < 0.001 (Wilcoxon test). TBAg, tuberculosis antigens; PHA, phytohemagglutinin.